Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
about
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort studyPlasma total antioxidant capacity and peroxidation biomarkers in psoriasisPharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registriesCardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study.Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses.Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries.Cutaneous disorders in 500 diabetic patients attending diabetic clinic.Clinico-biochemical correlation between psoriasis and insulin resistanceA study of awareness and screening behavior of cardiovascular risk factors in patients with psoriasis and dermatologistsPsoriasis and increased prevalence of hypertension and diabetes mellitus.Analysis of cardiovascular risk factors and metabolic syndrome in korean patients with psoriasis.Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis.Lichen planus and dyslipidemia: a systematic review and meta-analysis of observational studies.Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells.The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years.Psoriasis and new-onset diabetes: a Danish nationwide cohort studyPsoriasis and metabolic disease: epidemiology and pathophysiologyIs the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort studyEvaluation of subclinical atherosclerosis in Egyptian psoriatic patients.Psoriasis and obesity: literature review and recommendations for management.Cardiovascular aspects of psoriasis: an updated review.Managing moderate-to-severe psoriasis in the elderly.Homocysteine plasma levels in psoriasis patients: our experience and review of the literature.Maladaptive Cardiac Autonomic Control during a Stress Reactivity Assessment Among Primary Care Patients with Metabolic Syndrome.Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease.Heart rate recovery is impaired in patients with psoriasisIncreased arterial stiffness in patients with psoriasis is associated with active systemic inflammation.Psoriasis as an Independent Risk Factor for Cardiovascular Disease: An Epidemiologic Analysis Using a National Database.Assessment of subclinical left ventricular dysfunction in patients with psoriasis by speckle tracking echocardiography: A Speckle Tracking Study.Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case-Control Study.Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study.Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity.Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.Platelet activation: a link between psoriasis per se and subclinical atherosclerosis--a case-control study.Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.Prevalence and extent of subclinical atherosclerosis in patients with psoriasis.
P2860
Q21135505-405E1175-A108-42D5-A6CF-8C75E5CD47F1Q26744708-4F41E4BA-5C52-4A76-AD3F-FCE763616BCCQ28730205-8B9D893D-9A47-454B-A84B-A5A6F3D030D2Q30275864-E92EFADF-927B-48AD-86F4-F24C98A4EB43Q33767803-CBF3CC17-F8C7-409C-8349-41D68ABF0273Q33823950-A67A13A4-11EF-4DB1-ACDF-F1D0ABAB764CQ34420240-E66D2558-2F13-422E-8AAD-D4485269B879Q35025966-3604FB9C-0EA0-480B-B227-291276B8B0C0Q35028089-95603AD8-80D5-4BC9-8240-7E430DE85885Q35069963-AFDB5D7E-2D7C-4957-97B8-125E4BE8A8C3Q35564637-C9641916-040D-4E57-834A-590CAB285E3BQ35770123-D584FA6B-F1BA-42F2-9374-CFBBB291DD80Q35896544-54554CF9-64EC-4018-BC5C-20808AB93828Q35923106-C927A028-69D3-45E2-BC15-47D3050685BEQ36316432-3E589184-2FA5-4A35-B2AC-2937A06A658EQ36408491-49EF37CC-8A41-4038-B3EF-C77F06B5E8A3Q37022693-30360D8D-8983-480E-9B84-5B7B09CE1FA3Q37102789-F3338805-9870-44EB-89C0-439684999B1CQ37201787-60E14448-BFF4-4E93-9070-797F170E727DQ37449514-DFE0E8A5-0443-48F9-9ED5-5A5F4CE7D0B5Q37690591-B235061A-BE53-450D-BEA2-4FBE8FC2A6C5Q37777037-8D796A15-BCA3-40E5-96A8-9E0C28A3306AQ38076496-225CA3BA-F165-43EB-9FAE-5711D74A69B4Q38189734-BE5880D0-0BAD-4B06-9CDA-D29A70ED443DQ38391127-E9813BD1-190A-430A-91C8-CBA808A4DF5AQ38751663-501266C5-08FD-4704-8778-3541BD325FB6Q39117416-C65D54A4-DDDE-4B07-AB01-BCF32657127DQ39375369-62116818-338B-4DB7-A4C9-8FB735270EC1Q39957189-41A32CDC-84AB-4CDD-8E56-BB8E788920A8Q40597678-A48F4080-BE8F-4250-9C2D-0D68A774A095Q40806779-0319A8C0-EFA9-4968-84EE-CA5F03260F5BQ41582154-1BB2B713-55A2-4766-8D22-BED8CC1CF3FBQ41693144-63175CB7-A320-4B4B-9ACA-3FF78BDC03F5Q41829124-EC31828D-F92D-4322-9DFB-14C77952AB6BQ42860247-AFD7D717-D8BF-4374-AA2A-F1E70683E074Q43578147-D9E936C6-122D-45AB-8E7E-AE93E1A16DE5Q44199127-B6E6581B-453D-41E2-889C-9C0442557A94Q44398860-C71E115E-8AAB-439E-8B2C-5956C12FA406Q44859412-5B8D5B30-33C8-4592-9CD8-B82CCE6ADCFFQ45249524-1B869306-4E07-4D2B-8B3B-B9E39F978C90
P2860
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
@ast
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
@en
type
label
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
@ast
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
@en
prefLabel
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
@ast
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
@en
P2093
P1433
P1476
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
@en
P2093
P356
10.1016/J.ATHEROSCLEROSIS.2006.07.011
P577
2006-08-30T00:00:00Z